Production and use of antigen tetramers to study antigen-specific B cells
- PMID: 38243093
- DOI: 10.1038/s41596-023-00930-8
Production and use of antigen tetramers to study antigen-specific B cells
Erratum in
-
Author Correction: Production and use of antigen tetramers to study antigen-specific B cells.Nat Protoc. 2024 Dec 24. doi: 10.1038/s41596-024-01131-7. Online ahead of print. Nat Protoc. 2024. PMID: 39719506 No abstract available.
Abstract
B cells generate antibodies that provide protection from infection, but also cause pathology in autoimmune and allergic conditions. Antigen-specific B cells can be detected by binding their surface antibody receptors with native antigens conjugated to fluorescent probes, a technique that has revealed substantial insight into B cell activation and function. This protocol describes the process of generating fluorescent antigen tetramer probes and delineates a process of enriching large samples based on antigen-specificity for high-resolution analyses of the antigen-specific B cell repertoire. Enrichment of tetramer-binding cells allows for detection of antigen-specific B cells as rare as 1 in 100 million cells, providing sufficient resolution to study naive B cells and IgE-expressing cells by flow cytometry. The generation of antigen tetramers involves antigen biotinylation, assessment of biotin:antigen ratio for optimal tetramer loading and polymerization around a streptavidin-fluorophore backbone. We also describe the construction of a control tetramer to exclude B cells binding to the tetramer backbone. We provide a framework to validate whether tetramer probes are detecting true antigen-specific B cells and discuss considerations for experimental design. This protocol can be performed by researchers trained in basic biomedical/immunological research techniques, using instrumentation commonly found in most laboratories. Constructing the antigen and control tetramers takes 9 h, though their specificity should be assessed before experimentation and may take weeks to months depending on the method of validation. Sample enrichment requires ~2 h but is generally time and cost neutral as fewer cells are run through the flow cytometer.
© 2024. Springer Nature Limited.
References
Publication types
MeSH terms
Substances
Grants and funding
- R01AI122912/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- R01AI158728/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- R01AI167009/U.S. Department of Health & Human Services | National Institutes of Health (NIH)
- R01 AI122912/AI/NIAID NIH HHS/United States
- R01 AI158728/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
